Antibacterial in your toothpaste may combat severe lung disease

A common antibacterial substance found in toothpaste may combat life-threatening diseases such as cystic fibrosis, or CF, when combined with an already FDA-approved drug. Michigan State University researchers have found that when triclosan, a substance that reduces or prevents bacteria from growing, is combined with an antibiotic called tobramycin, it kills the cells that protect the CF bacteria, known as […]

Continue reading »

How the power of mathematics can help assess lung function

Researchers at the University of Southampton have developed a new computational way of analysing X-ray images of lungs, which could herald a breakthrough in the diagnosis and assessment of Chronic Obstructive Pulmonary Disease (COPD) and other lung diseases. A multi-disciplinary team of mathematicians, clinicians, and image specialists from three University of Southampton faculties has devised a method for numerically describing […]

Continue reading »

By 2030, prostate and lung cancers expected to be most common cancers among HIV population

Despite declines in cancer incidence rates among HIV-infected people, cancer will remain a significant concern as this patient population ages. By 2030, prostate and lung cancers are projected to be the most common cancers among individuals aging with HIV. The findings are published in Annals of Internal Medicine. Due to their weakened immune systems, people living with HIV have a […]

Continue reading »

Drug reduces size of some lung cancer tumors, relapse rate after surgery

A drug given to early stage lung cancer patients before they undergo surgery showed major tumor responses in the removed tumor and an increase in anti-tumor T-cells that remained after the tumor was removed, which resulted in fewer relapse cases in the patients. The research teams at the Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy, the Johns Hopkins Sidney Kimmel […]

Continue reading »

New liquid biopsy-based cancer model reveals data on deadly lung cancer

Small cell lung cancer (SCLC) accounts for 14 percent of all lung cancers and is often rapidly resistant to chemotherapy resulting in poor clinical outcomes. Treatment has changed little for decades, but a study at The University of Texas MD Anderson Cancer Center offers a potential explanation for why the disease becomes chemoresistant, and a possible avenue to explore new […]

Continue reading »

Early intervention may minimise later lung problems

A major study has found that controlling asthma through appropriate monitoring and medication is among several variables that can affect whether someone develops chronic obstructive pulmonary disease (COPD) in later life. The University of Melbourne-led study, published in The Lancet Respiratory Medicine, was the world’s first to characterise lung function trajectories that could lead to COPD in a large general […]

Continue reading »
1 2 3